Key result
Endothelial cells produce a lipoxygenase metabolite (LOX) that, along with PGI2, decreases platelet adhesion to endothelial cells and thrombogenic surfaces.
Population
Monolayers of cultured human endothelial cells
Comparison
Incubation with 14C-arachidonic acid and… vs Uninhibited state or different combinations of…
Design
Preclinical
Authors
Loading...
Hypothesis-generating for endothelial anti-adhesive mechanisms; validation in human models required before clinical relevance.
Endothelial cells produce a lipoxygenase-derived metabolite that, alongside PGI2, acts to repel platelets and decrease adhesion, providing insight into platelet-endothelial interactions.
Buchanan et al. (1985) studied this question. Inhibition of LOX and/or PGI2 was evaluated on Platelet adhesion to cultured endothelial cells. Endothelial cells produce a lipoxygenase metabolite (LOX) that, along with PGI2, decreases platelet adhesion to endothelial cells and thrombogenic surfaces.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: